FIELD: medicine.
SUBSTANCE: method is based on immune response antigen-antibody combined with detection of specific antibodies IgG and/or IgE concentration by means of immune-enzyme analysis. Concentration of IgG and/or IgE specific with respect to allergens contained in various SBFS is detected by means of test-system including antigen pattern - gross protein-peptide fractions extracted from various SBFS, notably: therapeutic (high-hydrolysed) preparations, therapeutic-preventive preparations (partially-hydrolysed breast milk substitute and phytalbumin-based), native protein-based breast milk substitute preparations and breast milk. And in case of increased concentration of specific IgG more 10 mcg/ml and/or detected specific IgE concentrated more 5 ng/ml, somato-allergic reaction (SAR) development risk is diagnosed with respect to specific SBFS.
EFFECT: increased accuracy and reliability of diagnostics somato-allergic reaction (SAR) development risk.
2 cl, 4 ex, 6 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| WAY OF CREATION OF FOOD ALLOWANCE FOR CHILDREN WITH FOOD ALLERGY | 2007 |
|
RU2362168C2 |
| SPECIALISED PRODUCT WITH A PROBIOTIC BASED ON A COMPLETE WHEY PROTEIN HYDROLYSATE FOR NUTRITION OF CHILDREN FROM BIRTH | 2020 |
|
RU2761534C1 |
| METHOD FOR PREVENTING NUTRITIONAL INSUFFICIENCY IN CHILDREN SUFFERING HIRSCHSPRUNG DISEASE | 2018 |
|
RU2694839C1 |
| METHOD OF PREPARING BACTERIAL FERMENT FOR FERMENTED-MILK PRODUCT | 2000 |
|
RU2169472C2 |
| NEWLY IDENTIFIED PEPTIDES FOR USE IN INDUCTION OF ORAL TOLERANCE IN YOUNG MAMMALS | 2013 |
|
RU2668155C1 |
| METHOD OF TREATING AND PREVENTING GASTROINTESTINAL AND OTHER IMMUNODEFICIENT DISEASES WITH CHRONIC INFLAMMATORY SYNDROME | 2018 |
|
RU2708373C2 |
| METHOD OF PRODUCING ENZYMATIC HYDROLYSATE OF WHEY PROTEIN WITH AVERAGE DEGREE OF HYDROLYSIS | 2008 |
|
RU2375910C1 |
| METHOD OF EXAMINATION OF CHILDREN WITH DISTROPHIC FORM OF CONGENITAL EPIDERMOLYSIS BULLOSA | 2017 |
|
RU2657542C1 |
| METHOD OF PREDICTING THE COURSE OF PREGNANCY AND DETERMINING THE DEGREE OF RISK OF EMBRYO/FETAL DEVELOPMENT DISORDERS AND THE BIRTH OF A CHILD WITH VARIOUS NON-GENETIC PATHOLOGY | 2022 |
|
RU2808266C1 |
| RECOMBITANT PLASMID DNA pET21-VP40VE CONTAINING THE GENE FOR THE MATRIX PROTEIN VP40 OF EBOLA VIRUS AND THE RECOMBITANT PROTEIN VP40-VE OBTAINED AS A RESULT OF THE GENE EXPRESSION FOR THE PROTEIN VP40 OF EBOLA VIRUS USING THE RECOMBITANT PLASMID DNA pET21-VP40VE AND EXHIBITING IMMUNOGENIC AND ANTIGENIC PROPERTIES | 2020 |
|
RU2742511C1 |
